BIS(4-CARBAMIMIDOYLPHENYL)TEREPHTHALATE

ID: ALA183814

Max Phase: Preclinical

Molecular Formula: C22H18N4O4

Molecular Weight: 402.41

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Di[4-Amino(Imino)Methylphenyl] Terephtalate
Synonyms from Alternative Forms(1):

    Canonical SMILES:  N=C(N)c1ccc(OC(=O)c2ccc(C(=O)Oc3ccc(C(=N)N)cc3)cc2)cc1

    Standard InChI:  InChI=1S/C22H18N4O4/c23-19(24)13-5-9-17(10-6-13)29-21(27)15-1-2-16(4-3-15)22(28)30-18-11-7-14(8-12-18)20(25)26/h1-12H,(H3,23,24)(H3,25,26)

    Standard InChI Key:  CTQZULQMEBBXGY-UHFFFAOYSA-N

    Associated Targets(Human)

    A549 127892 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    MCF7 126967 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    SF-268 49410 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    NCI-H460 60772 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Pneumocystis carinii 749 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    DNA 1199 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Glutamate NMDA receptor 6467 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 402.41Molecular Weight (Monoisotopic): 402.1328AlogP: 2.69#Rotatable Bonds: 6
    Polar Surface Area: 152.34Molecular Species: BASEHBA: 6HBD: 4
    #RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
    CX Acidic pKa: CX Basic pKa: 11.83CX LogP: 3.14CX LogD: -1.68
    Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.22Np Likeness Score: -0.08

    References

    1. Vanden Eynde JJ, Mayence A, Huang TL, Collins MS, Rebholz S, Walzer PD, Cushion MT..  (2004)  Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia.,  14  (17): [PMID:15357989] [10.1016/j.bmcl.2004.06.034]
    2. Vanden Eynde JJ, Mayence A, Johnson MT, Huang TL, Collins MS, Rebholz S, Walzer PD, Cushion MT, Donkor IO.  (2005)  Antitumor and Anti-Pneumocystis Carinii Activities of Novel Bisbenzamidines,  14  (3): [10.1007/s00044-005-0130-2]
    3. Berger ML, Maciejewska D, Vanden Eynde JJ, Mottamal M, Żabiński J, Kaźmierczak P, Rezler M, Jarak I, Piantanida I, Karminski-Zamola G, Mayence A, Rebernik P, Kumar A, Ismail MA, Boykin DW, Huang TL..  (2015)  Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.,  23  (15): [PMID:26117647] [10.1016/j.bmc.2015.06.012]

    Source